As of December 31, 2025, Physiomics Plc carries a market capitalization of 129.16M, placing it among publicly traded companies globally. Its enterprise value stands at 103.46M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 129.16M |
| Enterprise Value | 103.46M |
Physiomics Plc's next confirmed earnings release is scheduled for March 11, 2027.
| Earnings Date | 3/11/2027 |
As of December 31, 2025, Physiomics Plc has 453.21M shares outstanding.
| Shares Outstanding | 453.21M |
These figures are as of December 31, 2025.
| PB Ratio | 3.29 |
| P/TBV Ratio | 3.31 |
As of December 31, 2025, Physiomics Plc maintains a current ratio of 3.30, meaning it holds 3.3x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 3.30 |
| Quick Ratio | 1.56 |
As of the close on October 22, 2026, Physiomics Plc's stock has gained approximately 21.79% over the past 52 weeks. The 50-day moving average sits at 0.50, while the 200-day moving average is 0.49.
| 52-Week Price Change | 21.79% |
| 50-Day Moving Average | 0.50 |
| 200-Day Moving Average | 0.49 |
These figures are as of December 31, 2025. Total book value stands at 39.30M, with working capital of 38.00M providing operational flexibility.
| Cash & Cash Equivalents | 25.70M |
| Net Debt | -25.70M |
| Equity (Book Value) | 39.30M |
| Book Value Per Share | 0.09 |
| Working Capital | 38.00M |
Physiomics Plc's most recent stock split took place on December 19, 2016 with a 100:1 split ratio.
| Last Split Date | 12/19/2016 |
| Split Ratio | 100:1 |
Already premium?